Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02724930 · ClinicalTrials.gov registry record · NA

Cooperative Pain Education and Self-management

A NA study of Chronic Low Back Pain, sponsored by VA Connecticut Healthcare System.

Completed
Registry status
NA
Development phase
135
Enrollment target
3
Study locations

NCT02724930: Completed NA study of Chronic Low Back Pain, sponsored by VA Connecticut Healthcare System.

NCT02724930 is a NA study of Chronic Low Back Pain that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 135 participants, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02724930, a NA study of Chronic Low Back Pain, has completed, sponsored by VA Connecticut Healthcare System.

COMPLETED
Registry status
NA
Development phase
135 participants
Enrollment target
3
Study locations

Study Summary

This study will test the effectiveness of using enhanced facilitation strategies on implementation of an automated Interactive Voice Response (IVR) system as a means to remotely deliver in-home self-management support to Veterans with chronic pain. The implementation intervention uses an enhanced facilitation approach paired with automated case finding and direct patient outreach to encourage uptake of Cooperative Pain Education and Self-management (COPES). A nested effectiveness study will measure pre-post differences in pain-relevant outcomes (pain intensity, physical functioning and physical activity). The investigators will use a stepped wedge cluster design in which clusters will be randomized to the timing of the introduction of enhanced COPES implementation. Investigators will assess the efficacy of the facilitation based implementation strategy by evaluating COPES uptake in the implementation settings.

Primary Outcome

Patient enrollment measured as the probability an eligible patient enrolls in Cooperative Pain Education and Self-management (COPES).

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced facilitation of COPES

Study Locations (3)

California

  • VA Palo Alto Healthcare System - Menlo Park

Indiana

  • Richard L. Roudebush VA Medical Center - Indianapolis

Massachusetts

  • VA Boston Healthcare System - Brockton

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2018-06-25
Est. Completion 2020-08-27
Phase NA
VA Connecticut Healthcare System

26 total trials

What the finished NCT02724930 record still lists

NCT02724930 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Enhanced facilitation of COPES is the first listed.

NCT02724930 reports a single indexed study location in California, Indiana, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02724930 about?

NCT02724930 is a clinical study titled "Cooperative Pain Education and Self-management". This study will test the effectiveness of using enhanced facilitation strategies on implementation of an automated Interactive Voice Response (IVR) system as a means to remotely deliver in-home self-management support to Veterans with chronic pain. The implementation intervention uses an enhanced fa...

What is the current status of trial NCT02724930?

This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2018-06-25. Estimated completion is 2020-08-27.

What conditions does trial NCT02724930 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT02724930?

The interventions under investigation include: Enhanced facilitation of COPES (BEHAVIORAL).

Who is sponsoring clinical trial NCT02724930?

This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02724930 being conducted?

This trial has 3 study locations across California, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02724930's enrollment target sits among peer trials

135 27th of 71 higher than 45 of 71 other Chronic Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00870129 · 135 participants · NA

    Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

  • NCT03666000 · 135 participants · Phase 1

    Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • NCT04891510 · 135 participants · NA

    A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

  • NCT05121051 · 135 participants · Phase 2

    Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02724930, the US trial registry maintained by the National Library of Medicine. NCT02724930 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.